Role of Helicobacters in Neuropsychiatric Disease: A Systematic Review in Idiopathic Parkinsonism
Open Access
- 8 July 2020
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (7) , 2159
Abstract
Interest in an aetiopathogenic role for Helicobacter in neuropsychiatric diseases started with idiopathic parkinsonism (IP), where the cardinal signs can be assessed objectively. This systematic review, using an EMBASE database search, addresses Oxford Centre for Evidence-Based Medicine based questions on the inter-relationship of Helicobacter and IP, the benefits of eradicating Helicobacter in IP and the outcome of not treating. The search strategy was based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines: 21 of 204 articles met the inclusion criteria. The results show that the assumption that any benefit of Helicobacter eradication results from improved levodopa bioavailability is unjustified. The inter-relationship between Helicobacter and IP is well-established. H. pylori virulence markers (associated with autoimmunity and immune tolerance) influence the risk, severity and progression of IP. The birth cohort effect for virulence marker antibodies, seen in controls, is obliterated in IP, suggesting causality. Successful H. pylori eradication in IP is disease-modifying (even in anti-parkinsonian treatment-naïve patients) but not preventive. Hypokinesia regresses with eradication and overall motor severity lessens. Eradication may influence gastrointestinal microbiota adversely, unlocking the next stage in the natural history, the development of rigidity. Failed eradication worsens hypokinesia, as does the presence/persistence of H. pylori at molecular level only. Adequate prognostic assessment of the consequences of not treating Helicobacter, for IP, is prevented by a short follow-up. We conclude that Helicobacter is a pathophysiological driver of IP.Keywords
Funding Information
- Psychiatry Research Trust (WPI)
This publication has 91 references indexed in Scilit:
- Association between Helicobacter pylori and mortality in the NHANES III studyGut, 2013
- Health impact of probiotics - vision and opportunitiesGut Pathogens, 2012
- Treatment for Helicobacter pylori infection and risk of parkinson’s disease in DenmarkEuropean Journal of Neurology, 2012
- Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance studyGut Pathogens, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Localization of Helicobacter spp. in the fundic mucosa of laboratory Beagle dogs: an ultrastructural studyVeterinary Research, 2011
- Genome sequence of Helicobacter suis supports its role in gastric pathologyVeterinary Research, 2011
- Differential Effect of Helicobacter pylori Eradication on Time‐Trends in Brady/Hypokinesia and Rigidity in Idiopathic ParkinsonismHelicobacter, 2010
- The development and validation of a short measure of functioning and well being for individuals with Parkinson's diseaseQuality of Life Research, 1995
- ParkinsonismNeurology, 1967